EZH2 and prostate carcinoma: Li et al. demonstrate that the silence of EZH2 inhibited cell growth and the cell cycle, and promoted the progression of apoptosis of prostate cancer stem cells (PCSC), and EZH2 was essential for PCSC growth [17].